Introduction
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by the production of autoantibodies against a variety of nuclear and cell surface antigens, resulting in immune-complex mediated damage to vascular, dermatological, renal, neurological and rheumatological tissues. The aetiology of SLE is complex, with a combination of multiple genes and environmental factors determining both susceptibility and disease phenotype.
Spontaneous murine models of SLE, such as the New Zealand, BXSB and MRL mouse strains, have been widely used to dissect the complex genetic component of SLE.
Comparison of the many linkage studies performed in these lupus-prone strains illustrates the complexity of this disease. Numerous disease susceptibility loci have been identified, with some loci, such as distal chromosome 1, mid to distal chromosome 4, proximal chromosome 7 and proximal chromosome 17 (the H2 complex) being linked to disease in different murine models. 1 However, it is also clear that several intervals are strain-specific, confirming the genetic complexity of the disease and indicating the presence of extensive heterogeneity in the genes contributing to SLE pathogenesis. More recently, gene-targeting technology has allowed researchers to investigate the impact of a single gene on murine physiology. There is, however, accumulating evidence that genetic factors other than the actual disrupted gene can influence the resulting phenotype of the knockout mouse. In this regard, it is of note that the majority of the gene-targeted strains are initially developed on a hybrid genetic background between 129 and C57BL/6 (B6) mice, which has been shown to be spontaneously predisposed to development of humoral autoimmunity with low levels of glomerulonephritis. [2] [3] [4] [5] The initial knockout strain is then usually backcrossed onto B6 in order to remove as much 129 genome as possible. However, despite 10 or more generations of backcrossing, a considerable 129-derived genome interval, flanking the targeted gene, will remain. We have previously shown that a number of genetic loci, derived from both 129 and B6, are linked to the development of disease in the (129 Â B6) mice, with the most statistically significant of these being a 129-derived interval on distal chromosome 1 linked to increased autoantibody production. 6 This region has been consistently linked to autoimmune traits in a number of lupus-prone strains, including NZB (Nba2), 7, 8 NZM2410 (Sle1) 9 and BXSB (Bxs3). 10, 11 A congenic strain, comprising the 129-derived locus on distal chromosome 1 on a B6 background, a combination commonly created by backcrossing onto B6 a knockout strain in which the gene located in that region has been inactivated in 129 embryonic stem cells, also developed an autoimmune phenotype. The humoral autoimmunity in this congenic strain was indistinguishable to that observed in a mouse carrying a deletion of the Apcs gene, located within the lupus-linked genomic region on distal chromosome 1 and considered as a candidate gene for murine SLE. 6 Therefore, backgroundderived genes can significantly contribute to the phenotype observed in knockout strains even when the mice have been extensively backcrossed onto the B6 strain, greatly complicating the interpretation of the phenotypic analysis of gene-targeted animals.
The influence of background genes on the development or modification of spontaneous autoimmune disease is well known, especially with respect to the lpr and Yaa disease-susceptibility genes.
12-14 Not surprisingly important effects of the genetic background on the expression of autoimmunity have also been reported in gene-targeted mice. 5, 15, 16 For example, C1q deficiency, a condition that in humans is strongly associated with the development of a lupus-like disease, 17 in mice appears to have a disease-accelerating effect only in lupus-prone strains, including the (129 Â B6) genetic background. 3, 16 Likewise, inactivation of the FcgRIIB gene results in the development of a lupus-like phenotype in the context of the B6 genomic background, but not the BALB/c genomic background. 15 In this example, it is of note that two recessive B6-derived loci outside the targeted region were linked to the development of the disease phenotype. 18 Thus, SLE exists as a complex-trait disorder in which specific combinations of susceptibility alleles are required for the expression of the full phenotype.
In order to identify loci outside the C1qa locus that modify the autoimmunity observed in (129 Â B6).C1qa À/À mice we carried out a linkage analysis to both autoantibody production and nephritis in a new cohort of (129 Â B6)F2.C1qa À/À mice. In addition, we combined the data from this cohort with data from a previously published cohort of (129 Â B6)F2 wild-type mice, 6 in order to expand the sample size and confirm our observations. We show here that a number of genetic loci outside the C1q locus on distal chromosome 4 are linked to autoimmunity, both confirming previously described loci and identifying novel regions in this strain combination.
Results
Mapping of loci predisposing to lupus in the (129 Â B6).C1qa
À/À mice The observation that 129.C1qa
À/À and B6.C1qa À/À mice did not develop any autoimmune traits 16 while the (129 Â B6).C1qa À/À mice developed a lupus-like disease 3 suggest that the disease-modifying loci may arise as a result of interaction between specific combinations of alleles inherited from both the 129 and B6 parental strains. In order to investigate the genetic contribution of 129 and B6 genes to the lupus-like disease observed in the (129 Â B6).C1qa À/À mice, we generated a new cohort of (129 Â B6)F2.C1qa À/À animals and monitored these for a year. In this cohort of C1q-deficient mice, anti-nuclear antibodies (ANA) were detected in 38% (median 0, range 0-10240), anti-chromatin antibodies (Abs) in 58% (median: 2.23, range 0-4.0), anti-double-stranded DNA (anti-dsDNA) Abs in 18% (median 0; range 0-2560) and anti-single-stranded DNA (anti-ssDNA) Abs in 85% of the mice. Histological evidence of glomerulonephritis (above grade I) was found in 32% of the mice.
Interval mapping demonstrated significant linkage to ANA (LOD ¼ 4.0, P ¼ 9.9 Â 10 À5 , Figure 1a ), anti-dsDNA Abs (LOD ¼ 5.3, P ¼ 4.9 Â 10 À6 , Figure 1b ) and antissDNA Abs (LOD ¼ 5.5, P ¼ 3.1 Â 10
À6
, Figure 1c ) at a locus approximately 95 cM from the centromere of chromosome 1 in the (129 Â B6)F2.C1qa À/À cohort. Antichromatin Abs were also linked to this chromosome 1 region, but at a more distal locus and with a lower level of significance (LOD ¼ 2.2, P ¼ 6.3 Â 10
À4
, Figure 1d ). All these loci were derived from 129.
In addition to the linkage observed on distal chromosome 1, ANA titres were linked to a locus on mid-distal chromosome 3, albeit with a reduced degree of significance (LOD ¼ 2.3, P ¼ 5 Â 10 À4 , Figure 2 ). This locus was derived from the B6 background. In this context, it is of note that QTL analysis of the mid-distal region of chromosome 4 could not be applied to the (129 Â B6)F2.C1qa
À/À mice as this region was of fixed 129 origin.
Owing to the reduced variability in the glomerulonephritis (GN) data compared to the autoantibody titre data, the linkage to GN was determined using two methods -as a regular quantitative trait, and in an analysis of extremes, where only mice that were clearly negative or positive were included. Both these analyses showed that GN was linked to a 129-derived region of proximal chromosome 7 in the (129 Â B6)F2.C1qa Confirmation of linkage analysis data in a combined cohort of (129 Â B6)F2.C1qa À/À and (129 Â B6)F2 mice Overall the study of the (129 Â B6)F2.C1qa À/À cohort confirmed a number of the 129 and B6 loci previously described as being associated with SLE traits, but failed to support others. 6 In order to increase the power of our study, we repeated the QTL analysis in a larger data set, obtained by combining data from the (129 Â B6)F2.C1qa À/À mice presented in this study with data from a previously reported (129 Â B6)F2 intercross, 6 resulting in 297 female mice. In this analysis, the medial and distal regions of chromosome 4 were not included. The results from the IgG anti-ssDNA ELISA and IgG anti-chromatin ELISA assays were ranked, as described in the Materials and methods section, in order to compare the data from the two cohorts. The ranking method was verified by comparing the patterns of genome-wide linkage to both ranked and unranked ELISA data in a single cohort, and confirming that the linkage patterns were comparable in both position and magnitude of linkage.
The combined cohort of (129 Â B6)F2.C1qa Figure 3d ) to a locus on distal chromosome 1 with a peak of around 95 cM. All of the above disease traits were linked to the distal chromosome 1 region with a higher degree of significance in the combined than the individual cohorts. It is of note that the linkage to IgG anti-chromatin Abs mapped to a more distal region of chromosome 1 than the other autoantibodies in the (129 Â B6)F2.C1qa À/À cohort, whereas in the combined cohort analysis it mapped to the same locus as the other autoantibodies (B95 cM from the centromere). Akin to the linkage on chromosome 1, the ANA linkage to middistal chromosome 3 was observed in the combined cohort of (129 Â B6)F2.C1qa
À/À and (129 Â B6)F2 mice. ANA titre was linked to a locus of around 50 cM from the centromere, again with an increased degree of significance in the combined cohort (LOD ¼ 8.0, P ¼ 9 Â 10 À9 , Figure 4 ).
To investigate any potential interactions between the B6-derived gene(s) on chromosome 3 and the 129-derived gene(s) on chromosome 1, we grouped the mice accordingly to their genotype at these two loci and compared ANA titres. We selected a marker at the peak of the linkage to ANA ((D1Mit206 (95.8 cM) on chromosome 1 and D3Mit103 (51.1 cM) on chromosome 3) to define the genotype of the mice. As illustrated in Figure 5 , ANA levels were significantly higher in the mice carrying two B6 alleles on chromosome 3 in combination with one or two 129 alleles on chromosome 1 compared to all the other genetic combinations. Of note the ANA À/À mice. Centimorgan positions were deduced by interval mapping, anchoring marker locations according to data from www.informatics.jax.org. Intermittent dashed lines indicate threshold over which linkage is considered suggestive; dashed lines indicate threshold over which linkage is considered significant; dotted lines indicate threshold over which linkage is considered highly significant (see Materials and methods). LOD scores were generated with Map Manager QTb29. Autoimmunity in 129 and C57BL/6 mice Y Heidari et al titres were not significantly different between the animals homozygous or heterozygous for the 129-derived segment on chromosome 1, when in combination with B6 homozygosity on chromosome 3 suggesting that the presence of a single 129-derived allele on chromosome 1 was sufficient to drive loss of tolerance to nuclear antigens. This analysis provided further support to the hypothesis that the B6-derived loci on chromosome 3 tend to operate in a recessive manner while the 129-derived loci on chromosome 1 operate in a dominant fashion. As in the (129 Â B6)F2.C1qa À/À cohort, the linkage analysis of GN in the combined cohort was carried out using both a quantitative trait analysis and analysis of extremes. Using the quantitative trait analysis method, linkage of GN to a 129-derived locus on proximal chromosome 7 was confirmed with an increased significance (LOD ¼ 3.8, P ¼ 1.6 Â 10
À5
, Figure 6a ). This was confirmed by the analysis of extremes which showed a linkage to D7Mit230 (26.3 cM), with a w 2 of 11.72, P ¼ 0.0028 (Table 1) . Interestingly, a further linkage to GN, this time derived from a B6 locus, was observed in the combined cohort. Located on proximal chromosome 13, this locus reached the cutoff for suggestive linkage À/À and wild-type (129 Â B6)F2 mice. Centimorgan positions were deduced by interval mapping, anchoring marker locations according to data from www.informatics.jax.org. Intermittent dashed lines indicate threshold over which linkage is considered suggestive; dashed lines indicate threshold over which linkage is considered significant; dotted lines indicate threshold over which linkage is considered highly significant. Thresholds were determined by 1000 cross-and trait-specific permutation tests. (Table 1) .
Discussion
Multiple genetic loci are known to contribute to the development and pathogenesis of SLE in mice and in humans. In this study, we have provided further evidence that epistatic interactions between 129 and B6 mice, even though autoimmunity has not been reported in either of the strains, can lead to a spontaneous lupuslike phenotype. In particular, we confirmed that a 129-derived region of chromosome 1, when expressed in context of the B6 genome, is strongly linked to autoantibody production. Consistent with this, the B6 genome contributed to the autoimmune phenotype with an interval on chromosome 3, displaying a highly significant linkage to anti-nuclear autoantibodies. Interestingly glomerulonephritis was linked to different chromosomes: a 129 region on proximal chromosome 7 and a B6 interval on chromosome 13 ( Figure 7) . A genome-wide scan of the (129 Â B6)F2.C1qa À/À mice demonstrated linkage of lupus serological markers (ANA, anti-dsDNA Abs, anti-ssDNA Abs and antichromatin Abs) to a 129-derived locus on distal chromosome 1 -recently named Sle 16 (http://www.informatics. jax.org). This is in agreement with our previous study, 6 in which SLE traits were mapped in (129 Â C57BL/6)F2 wild-type and (129 Â C57BL/6)F2.ApcsÀ/À mice. The linkages were markedly increased when we enlarged the sample size by combining data from the 10 all of which are strongly associated with the production of autoantibodies to nuclear antigens. The significance of this chromosome 1 locus has also been confirmed by several congenic dissection analyses. 1, 20 Furthermore, recent genomic characterization of the Sle1b locus (located between 171.8 and 173.1 Mbp) has identified a highly polymorphic cluster of Slam/Cd2 family genes, encoding key regulators of lymphocyte function, as the strongest candidate genes for mediating the Sle1b autoimmune phenotype. 21 The autoimmune-associated haplotype of the lupus-prone NZM2410 (NZW) strain, named the Slam/Cd2 haplotype 2, is also present in the 129/SvJ mice, 21 indicating that these two strains may share the same pathways leading to loss of peripheral tolerance when in combination with one or more polymorphic genes in the B6 genome. These observations give compelling evidence for the presence of a 129 locus influencing systemic autoimmunity on telomeric chromosome 1 as revealed in the context of B6 genome. Whether this 129 lupus locus can contribute to the development of autoimmunity on other genetic backgrounds is still unknown.
In common with the distal chromosome 1 region, numerous studies have demonstrated linkage of SLE traits to proximal chromosome 7. In this study, we confirm that there is a 129-derived locus on proximal chromosome 7 linked to GN. 6 Furthermore, this locus colocalizes with a number of loci from various lupusprone mouse strains, including Sle3 (NZM2401 locus linked to GN and ANA); 20, 22 Lbw5 (NZW locus linked to mortality), 23 Lmb3 (MRL locus linked to splenomegaly, lymphadenopathy, anti-dsDNA Abs), 24 Nba3 (NZB locus linked to GN) 25 and Nba5. 26 As this is an analogous situation to that on distal chromosome 1, a similar haplotype-based candidate gene identification strategy could be applied, especially as murine single nucleotide polymorphism (SNP) databases continue to increase in both SNP density and the number of typed strains. The presence of a 129-derived lupus locus on proximal chromosome 7 also has impact on the phenotype of any targeted gene in this region -it is conceivable that the 129 gene(s) that predispose to GN in the (129 Â B6)F2 strain could modify or augment the GN observed in a knockout strain. Recently a knockout of the Bcl-2 associated Â protein (Bax) gene, located on proximal chromosome 7, was reported to have GN as one of its resulting phenotypes. 27 In light of the data presented herein, one cannot exclude the possibility that the observed GN phenotype may have been due to the surrounding 129 genome, and not the inactive Bax gene.
A previously described locus of B6 origin on chromosome 3, 6 was here confirmed to be linked to ANA production in both the (129 Â B6)F2.C1qa À/À mice and combined cohorts. Unlike the loci on chromosomes 1 and 7, this locus has not been consistently linked to lupus disease traits, the SLE-associated loci Sles3 and Bxs5 being proximal (between 20 and 40 cM) to our observed linkage peak. However, they intriguingly both involve non-autoimmune strains; in the case of Sles3, NZWxC57BL/6 heterozygosity, 1 and in the case of Bxs5, C57BL/10 homozygosity. 11 The confirmation of a B6-derived locus on chromosome 3 that modifies ANA titres (in combination with 129-derived genes) highlights the likelihood of epistatic interactions influencing the phenotype of a knockout strain, in spite of extensive backcrossing to B6.
The possibility of B6 genes influencing the phenotype of a knockout mouse was further underlined by the observation of B6-derived linkage to GN on proximal chromosome 13. This linkage was only observed in the combined analysis of (129 Â B6)F2.C1qa À/À and (129 Â B6)F2 mice, and had thus a less penetrant effect than the loci on chromosomes 1, 3 and 7. Nonetheless, such minor loci may together have a significant cumulative influence on the phenotype of a knockout strain bred onto the B6 background. Hence, it is important to identify both the genomic position and the resulting phenotypes of these loci. In this context, it is of note that we had previously reported a B6-derived suggestive linkage to anti-dsDNA Abs on the mid-distal region of chromosome 4. 6 However, this observation could not be validated in the current study as this region was of fixed 129-origin in the (129 Â B6)F2.C1qa À/À mice. Hence, we cannot exclude the potential effect of a minor B6-derived locus on distal chromosome 4.
In conclusion, we have identified linkage of lupus disease traits to loci present on chromosomes 1, 3, 13 and 7 in the 129 Â B6 mice ( Figure 7 ). As this is the strain combination of choice for gene-targeted mice, knowledge of the influence of parental genetic loci on the disease phenotype is critical if we are to avoid attributing false positive phenotypes to knockout strains.
Materials and methods

Mice
The C1q-deficient mice, C1qa
À/À were generated as previously reported 3 and the (129 Â B6)F1.C1qa À/À mice were generated by crossing 129.C1qa À/À female mice were produced and monitored for 1 year. The strain-and sex-matched wildtype (129 Â B6)F2 cohort was as previously described. 6 Mice were maintained in specific pathogen-free conditions, and all procedures were in accordance with institutional guidelines.
Serological analyses
Serum was collected at 12 months of age and assayed for autoantibodies. IgG ANA and IgG anti-dsDNA Abs were measured by indirect immunofluorescence using Hep-2 cell and Crithidia luciliae slides (The Binding Site, Birmingham, UK) respectively. 16 Serum samples were screened at a 1:80 (ANA) or 1:20 (anti-dsDNA Abs) dilution and the positive samples titrated to end point.
IgG anti-ssDNA Abs and anti-chromatin Abs were measured by ELISA as described previously. 28 For determination of anti-chromatin antibodies ELISA plates (Nunc-Immuno MaxiSorp, NUNC, Denmark) were coated with 50 ml of PBS Thimerosal (0.1 g/l) containing 0.5 mg/ml nucleohistones from calf thymus (Lorne laboratories Ltd, Reading, UK) at 41C overnight, then blocked with PBS 5% milk powder for 1 h at 371C. Sera diluted 1/100 in PBS 2% BSA 0.05% Tween20 were incubated for 1 h at 371C. For measuring anti-ssDNA Abs plates were coated with 50 ml of 10 mg/ml ssDNA (Sigma Chemical Co., Poole, UK) in sodium carbonate buffer pH 9.6 at 41C overnight and then blocked with 100 ml PBS 0.5% BSA. Samples were screened at a 1/100 dilution in PBS 2% BSA 0.05% Tween20 for 1 h at 371C with 50 ml/ well. Bound antibodies were detected with alkaline phosphatase (AP)-conjugated goat anti-mouse IgG (g-chain specific) (Sigma-Aldrich, Dorset, UK). The plates were developed using the substrate p-nitrophenyl phosphate (Sigma Chemical Co., Poole, UK). The OD of the reaction mixture at 405 nm wavelength was measured using an ELISA plate reader (Titertek Labsystems, Basingstoke, UK). Samples were tested in duplicate with a non-specific binding control and the results were expressed in arbitrary ELISA units (AEU) relative to serial dilutions of a standard positive sample derived from pooled autoimmune MRL/Mp.lpr/lpr serum. Serum samples were considered positive if above the mean 72s.d. of the blank. The intra-assay coefficient of variation was between 5 and 8%.
Histological analysis
All the mice were killed at 1 year of age. Kidney tissue was fixed in Bouin's solution for at least 2 h, transferred into 70% ethanol, and then processed into paraffin. Sections were cut, mounted, stained with periodic acidSchiff reagent and scored for GN. Glomerular histology was graded as follows: grade 0 -normal, grade I -focal hypercellularity in 10-25% of the glomeruli, IIhypercellularity involving 450% of the glomerular tuft in 25-50% of glomeruli, grade III -hypercellularity involving 450% of the glomerular tuft in 50-75% of glomeruli, grade IV -glomerular hypercellularity in 475% or crescents in 425% of glomeruli. Histological analysis was performed in a blinded fashion and 50 glomeruli per section were analysed.
Genotypic analysis
Genotyping of the (129 Â B6)F2.C1qa À/À cohort was carried out using polymorphic microsatellite markers, a standard polymerase chain reaction and either 4% MetaPhor agarose (Cambrex Bioscience Rockland, Rockland, ME, USA) or 16% polyacrylamide gels stained with ethidium bromide. The average marker density was one marker per 10 centimorgans (cM) across the autosomes, the positions and sequences of which were determined from the Mouse Genome Informatics (MGI) database (http://www.informatics.jax.org). The list of markers used is available on request.
Statistical analyses
All linkage analyses and interval mapping were conducted using MapManager QTb29 (ftp://mcbio.med.-buffalo.edu/pub/MapMgr/). 29 Marker maps were generated to determine the accuracy of genotyping, with all markers mapping to within 3 cM of the marker position in the MGI database. All centimorgans positions of markers referred to in this study are from the MGI database.
Anti-ssDNA and anti-chromatin ELISA data were log transformed prior to linkage analysis as this resulted in a more normalized distribution. As the ELISA assays for these two autoantibodies in the two cohorts of mice had been carried on separate occasions and using a different MRL/Mp.lpr/lpr standard positive sample, for the combined analysis of the two sets of data the samples in each group were ranked using uncategorized (continuous) arbitrary values and the ranked values were subsequently used for the quantitative trait locus (QTL) analysis.
Thresholds for suggestive, significant and highly significant linkages were determined using cohort-and trait-specific permutation tests, based on 1000 permutations of the data, in Map Manager QTb29. 29 A logarithm of odds ratio (LOD) of X2.0 (Pp9.9 Â 10 À4 ), of X3.6 (Pp2.5 Â 10
À5
) and of X5.7 (Pp2.0 Â 10 À6 ) was indicative of suggestive, significant and highly significant linkage, respectively, in the (129 Â B6)F2.C1qa
À/À cohort of mice. In the combined cohort of C1q-deficient and wild-type F2 mice, the threshold for suggestive, significant and highly significant linkages were LOD X2.1 (Pp7.9 Â 10 À4 ), X3.5 (Pp3.1 Â 10
) and X5.3 (Pp4.9 Â 10 À6 ), respectively. The calculated thresholds for suggestive, significant and highly significant linkages were similar across the different traits.
Glomerulonephritis score was analysed as both a quantitative trait in Map Manager and in an analysis of extremes, in which mice with a GN score of II or above were considered as positive for glomerulonephritis, and mice with a GN score of 0 were considered negative. All mice with grade I GN were excluded. Linkage to microsatellite markers was determined using a Chi square (w 2 ) test in an Excel (2003) spreadsheet. w 2 -values of over 12.9 (P ¼ 0.0016) was considered to be indicative of suggestive linkage. 30 Non-parametric data are presented as median, with range of values in parentheses unless otherwise stated. Statistics were calculated using GraphPad Prism version 3.0 (GraphPad Software, San Diego, CA, USA). One way ANOVA with Bonferonni;s multiple comparison tests were applied for analysis of multiple groups.
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